ES8200679A1 - Un procedimiento para la preparacion de derivados de carboestirilo. - Google Patents

Un procedimiento para la preparacion de derivados de carboestirilo.

Info

Publication number
ES8200679A1
ES8200679A1 ES495163A ES495163A ES8200679A1 ES 8200679 A1 ES8200679 A1 ES 8200679A1 ES 495163 A ES495163 A ES 495163A ES 495163 A ES495163 A ES 495163A ES 8200679 A1 ES8200679 A1 ES 8200679A1
Authority
ES
Spain
Prior art keywords
group
lower alkyl
substituted
phenyl
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES495163A
Other languages
English (en)
Other versions
ES495163A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP12045279A external-priority patent/JPS5643280A/ja
Priority claimed from JP12556579A external-priority patent/JPS5649360A/ja
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of ES495163A0 publication Critical patent/ES495163A0/es
Publication of ES8200679A1 publication Critical patent/ES8200679A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE CARBOESTIRILO, DE FORMULA (I), Y DE SUS SALES, EN LA QUE RU, R2, R3Y R4 PEDEN SER VARIOS TIPOS DE RADIALES; X ES UN ATOMO DE HALOGENO; Y ES UN RADICAL ALQUILENO INFERIOR, SUSTITUIDO O SIN SUSTITUIR CON GRUPOS HIDROXILO; N VALE 0-2, Y EL ENLACE CARBONO-CARBONO ENTRE LAS POSICIONES 3 Y 4 ES SENCILLO O DOBLE. CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III), EN LAS QUE R1, T2, R3, R4, X Y N TIENEN LA MISMA SIGNIFICACION QUE EN LA FORMULA (I), Y UNO DE W Y W'' ES HIDROGENO Y EL OTRO PUEDE SER -CH2-CH2,-CH2-CH(OH)-CH2-X! O YX1, SIENDO Y LO MISMO QUE EN FORMULA (I) Y X1 UN ATOMO DE HALOGENO.
ES495163A 1979-09-18 1980-09-18 Un procedimiento para la preparacion de derivados de carboestirilo. Expired ES8200679A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12045279A JPS5643280A (en) 1979-09-18 1979-09-18 Carbostyril derivative
JP12556579A JPS5649360A (en) 1979-09-28 1979-09-28 2-oxoquinoline derivative

Publications (2)

Publication Number Publication Date
ES495163A0 ES495163A0 (es) 1981-11-16
ES8200679A1 true ES8200679A1 (es) 1981-11-16

Family

ID=26458032

Family Applications (1)

Application Number Title Priority Date Filing Date
ES495163A Expired ES8200679A1 (es) 1979-09-18 1980-09-18 Un procedimiento para la preparacion de derivados de carboestirilo.

Country Status (19)

Country Link
US (1) US4482560A (es)
AR (2) AR230280A1 (es)
AT (1) AT376972B (es)
AU (1) AU518144B2 (es)
CA (1) CA1151172A (es)
CH (1) CH645892A5 (es)
DE (1) DE3034237A1 (es)
DK (1) DK158984C (es)
ES (1) ES8200679A1 (es)
FI (1) FI76322C (es)
FR (1) FR2465732A1 (es)
GB (1) GB2063869B (es)
IT (1) IT1129263B (es)
MX (1) MX6806E (es)
NL (1) NL187912C (es)
NO (1) NO154841C (es)
PT (1) PT71810B (es)
SE (1) SE439632B (es)
SU (1) SU1091857A3 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2901336A1 (de) 1979-01-15 1980-07-24 Boehringer Mannheim Gmbh Neue arylether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
CH655110A5 (de) * 1982-09-03 1986-03-27 Otsuka Pharma Co Ltd Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
GB8426584D0 (en) * 1984-10-19 1984-11-28 Beecham Group Plc Compounds
US4704390A (en) * 1986-02-13 1987-11-03 Warner-Lambert Company Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents
US4792561A (en) * 1986-05-29 1988-12-20 Syntex (U.S.A.) Inc. Carbostyril derivatives as combined thromboxane synthetase and cyclic-AMP phosphodiesterase inhibitors
US4921862A (en) * 1986-05-29 1990-05-01 Syntex (U.S.A.) Inc. Carbostyril derivatives as combined thromboxane synthetase and cyclic-amp phosphodiesterase inhibitors
DE3784401T2 (de) * 1986-07-31 1993-08-12 Otsuka Pharma Co Ltd Karbostyril-derivate und ihre salze, verfahren zu ihrer herstellung und diese enthaltende kardiotonische zusammensetzung.
FR2620704B1 (fr) * 1987-09-17 1991-04-26 Sanofi Sa Derives de (benzyl-4 piperidino)-1 propanol-2, leur preparation, leur utilisation comme antimicrobiens et les produits les contenant
US5227381A (en) * 1988-05-02 1993-07-13 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative
US5082847A (en) * 1990-07-18 1992-01-21 Syntex (U.S.A.) Inc. Carbostyril compounds connected via an oxyalkyl group with a piperidine ring and having pharmaceutical utility
JP2686887B2 (ja) * 1992-08-11 1997-12-08 キッセイ薬品工業株式会社 ピペリジノ−３，４−ジヒドロカルボスチリル誘導体
IT1264816B1 (it) * 1993-07-28 1996-10-10 Pergam Srl Procedimento per la preparazione di derivati del procedimento per la preparazione di derivati del 3,4-diidrocarbostirile 3,4-diidrocarbostirile
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
AU2001256733A1 (en) * 2000-05-16 2001-11-26 Takeda Chemical Industries Ltd. Melanin-concentrating hormone antagonist
EP1480953B2 (en) † 2003-01-09 2010-08-18 Otsuka Pharmaceutical Co., Ltd. Process for preparing aripiprazole
DE102008022221A1 (de) 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
US8541404B2 (en) 2009-11-09 2013-09-24 Elexopharm Gmbh Inhibitors of the human aldosterone synthase CYP11B2

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3629266A (en) * 1969-03-03 1971-12-21 Miles Lab (phenyl piperidino alkyl)3 4-dihydrocarbostyrils
US3910924A (en) * 1972-04-13 1975-10-07 Otsuka Pharma Co Ltd 3,4-Dihydrocarbostyril derivatives and a process for preparing the same
JPS48103590A (es) * 1972-04-13 1973-12-25
US4256890A (en) * 1972-09-14 1981-03-17 Otsukapharmaceutical Co., Ltd. 3,4-Dihydrocarbostyril derivatives and process for producing the same
JPS5239035B2 (es) * 1972-12-14 1977-10-03
JPS5310986B2 (es) * 1974-02-05 1978-04-18
JPS5310989B2 (es) * 1974-04-25 1978-04-18
US3994900A (en) * 1976-01-23 1976-11-30 E. R. Squibb & Sons, Inc. 6-(Or 8)-[[(substituted amino)alkyl]oxy(or thio)]-3,4-dihydro-4-phenyl-2(1H)-quinolinones
JPS609501B2 (ja) * 1976-05-07 1985-03-11 大塚製薬株式会社 新規３，４−ジヒドロカルボスチリル誘導体
US4210753A (en) * 1976-03-17 1980-07-01 Otsuka Pharmaceutical Co., Ltd. Carbostyril compounds
JPS5919541B2 (ja) * 1976-03-17 1984-05-07 大塚製薬株式会社 新規３，４−ジヒドロカルボスチリル誘導体
CH619453A5 (es) * 1976-03-17 1980-09-30 Otsuka Pharma Co Ltd
DE2719562C2 (de) * 1976-05-08 1986-05-07 Otsuka Pharmaceutical Co. Ltd., Tokio/Tokyo 3, 4-Dihydrocarbostyrilderivate, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten
JPS6019295B2 (ja) * 1977-03-04 1985-05-15 大塚製薬株式会社 カルボスチリル誘導体及びその製造法
JPS5416478A (en) * 1977-07-08 1979-02-07 Otsuka Pharmaceut Co Ltd 3,4-dihydrocarbostyril herivative
JPS54130587A (en) * 1978-03-30 1979-10-09 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
DE2827566A1 (de) * 1978-06-23 1980-01-10 Boehringer Mannheim Gmbh 1,2-dihydro-chinolin-2-on-derivate und verfahren zu ihrer herstellung
JPS5589221A (en) * 1978-12-28 1980-07-05 Otsuka Pharmaceut Co Ltd Antihistaminic agent
JPS5589222A (en) * 1978-12-28 1980-07-05 Otsuka Pharmaceut Co Ltd Antihistaminic agent
DE2901336A1 (de) * 1979-01-15 1980-07-24 Boehringer Mannheim Gmbh Neue arylether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
NO154841C (no) 1987-01-07
FI802905A (fi) 1981-03-19
CA1151172A (en) 1983-08-02
SE8006498L (sv) 1981-03-19
AU518144B2 (en) 1981-09-17
PT71810A (en) 1980-10-01
IT1129263B (it) 1986-06-04
ES495163A0 (es) 1981-11-16
AR230280A1 (es) 1984-03-01
CH645892A5 (de) 1984-10-31
DK158984B (da) 1990-08-13
FI76322B (fi) 1988-06-30
PT71810B (en) 1981-07-07
AU6238180A (en) 1981-05-28
AT376972B (de) 1985-01-25
DE3034237C2 (es) 1988-04-21
NL187912C (nl) 1992-02-17
FI76322C (fi) 1988-10-10
DK158984C (da) 1991-01-14
NO802762L (no) 1981-03-19
IT8068445A0 (it) 1980-09-18
DE3034237A1 (de) 1981-04-16
NL8005188A (nl) 1981-03-20
FR2465732A1 (fr) 1981-03-27
GB2063869B (en) 1983-05-25
GB2063869A (en) 1981-06-10
SE439632B (sv) 1985-06-24
SU1091857A3 (ru) 1984-05-07
US4482560A (en) 1984-11-13
DK394080A (da) 1981-03-19
NO154841B (no) 1986-09-22
MX6806E (es) 1986-07-30
AR230059A1 (es) 1984-02-29
FR2465732B1 (es) 1983-06-24
ATA465780A (de) 1984-06-15
NL187912B (nl) 1991-09-16

Similar Documents

Publication Publication Date Title
ES8200679A1 (es) Un procedimiento para la preparacion de derivados de carboestirilo.
ES486992A1 (es) Un procedimiento para la preparacion de un derivado de car- boestirilo
ES8301962A1 (es) Un procedimiento para la produccion de un derivado de carboslivilo.
SE8004783L (sv) Delta?722-1,2,4triazolin-5-on-derivat
IL66650A0 (en) Tricyclic ethers,their preparation and pharmaceutical compositions containing them
SE8200916L (sv) Karbostyrilderivat, forfarande for framstellning derav och hjertsterkande komposition som innehaller detsamma
SE8704599D0 (sv) Teobrominderivat
MY108076A (en) Cationic compound and cleaning composition.
AU529663B2 (en) Piperidine alkyl ethers of coumarin and quinoline
NZ194850A (en) Substituted oxirane-carboxylic acids pharmaceutical compositions
ES2019163A6 (es) Procedimiento para preparar derivados de imidazol.
DE69101673D1 (de) N-substituierte Alpha-Mercaptoalkylaminderivate, Verfahren zu ihrer Herstellung und hergestellte Zwischenprodukte, ihre Verwendung als Arzneimittel und diese enthaltende Zusammensetzungen.
IE43139L (en) Bis-biguanide compounds
ES8203867A1 (es) Procedimiento para la obtencion de derivados de benzotiazol
SE8102690L (sv) Karbostyrilderivat
ES8202818A1 (es) Un procedimiento para preparar derivados de tetrazolilcuma- rina
ES8105715A1 (es) Procedimiento de preparar derivados isoquinolinicos
ES8400743A1 (es) "procedimiento para la preparacion de compuestos de 1-fenilindazol-3-ona".
ES8203350A1 (es) Procedimiento para la fabricacion de derivados del pirazol
ES8205816A1 (es) Procedimiento para la preparacion de cardenolido-bis-digoto-xosidos
ES463228A1 (es) Procedimiento para preparar quinolinonas
ES2007666A6 (es) Procedimiento para preparar derivados de isoquinolina y composiciones farmaceuticas correspondientes.
ES8107202A1 (es) Procedimiento para preparar nuevos derivados de oxadiazolin-1,3,4-ona-5.
IL61771A0 (en) 4-amino-2,6-diaryl-tetrahydrothiopyrans,their preparation and pharmaceutical compositions containing them
GB2005254A (en) 6-( alpha -acylamino phenylacetamido)-penicillins

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303